France expands coverage of vaccinations… even 65-74 years old with complications can be beaten
Canada recommends “do not vaccinate people over 65”
viewer
Reuters reported on the 1st (local time) that France has expanded the coverage of the AstraZeneca vaccine so that people over 65 with complications can be beaten.
French Health Minister Olivier Berand said on a local news channel BFMTV, “Anyone 50 years old or older with a complication can get the AstraZeneca vaccine.” However, Citizens over the age of 75 can only be vaccinated with Pfizer-Bioentech and Modena vaccines, Berang added.
Previously, France stipulated that AstraZeneca vaccine can be vaccinated under the age of 65. This is because the clinical trial data for this vaccine in the elderly are limited.
At the end of January, French President Emmanuel Macron made a statement stating that the AstraZeneca vaccine was not effective for people over 65 years old, and then scammed a backlash from Britain, the first in the world to approve the emergency use of the vaccine.
However, data on the efficacy of the vaccine have since been accumulated, including an announcement by a Scottish researcher that the AstraZeneca vaccine has a very high preventive effect. In addition, it is interpreted that the authorities have eased the existing position due to the lack of vaccine supply from Pfizer-Bioentech and Modena in France.
On the other hand, other recommendations have been made in Canada, which has approved the use of the AstraZeneca vaccine in subjects over 18 years of age. On that day, Canada’s National Immunity Advisory Committee recommended that people over 65 should not get the AstraZeneca vaccine, as data on the efficacy of the vaccine were too limited.
However, the Committee also added that the’substantial evidence’ that can be confirmed in the country where the vaccine is actually vaccinated is potentially beneficial and there are no safety issues. Reuters added that the committee’s recommendations are not enforceable, but may influence health decisions in the future.
In the meantime, Pfizer and AstraZeneca’s COVID-19 vaccine has been shown to have a great effect on the elderly, according to the UK’s England Public Health Service (PHE). According to the AFP news agency, PHE researched the vaccination data collected from January, and found that 80% of the elderly people over 80 years of age who received the first dose of these vaccines had an effect of preventing hospitalization from 3 to 4 weeks after vaccination. .
PHE also found that these vaccines were also effective in reducing infection and severe transition in older people. In addition, both vaccines announced that they had a great effect in reducing COVID-19 infection even in the 70-year-old and older.
Four weeks after the first vaccination, the Pfizer vaccine’s preventative effect on symptomatic infection was 57-61% for those over 70 years old, and 60-73% for AstraZeneca. The Pfizer vaccine showed an 83% reduction in the number of COVID-19 deaths among those vaccinated over the age of 80. Data on the death toll of AstraZeneca, who started vaccination later than this, have not yet been obtained. British Health Minister Matt Hancock said, “The results of this new study are very good news.” “The results of this study may serve as a basis for explaining why the number of intensive care unit admissions for seniors aged 80 and over in the UK has dropped to a single digit over the past two weeks,” he said.
PHE’s Director of Infectious Diseases Mary Ramsey said, “Keep in mind that the vaccine’s preventive effect is not complete,” he said. “We don’t know how much these vaccines will reduce the transmission of COVID-19.” The AFP news agency said the results of the PHE study came while France and Germany were considering reverting the policy that AstraZeneca’s vaccine would not be vaccinated by age 65 or older due to concerns over efficacy.
/ Reporter Kihyuk Kim [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >